Main Article Content
Abstract
The current work aimed to study the effects of Ciprofloxacin (80mg/kg body weight) on levels of lipids (Cholesterol, Triglycerides, HDL, VLDL, and LDL) and liver enzymes (GOT, GPT, and Alkaline phosphatase) in albino mice for 3, 7 and 14 days using ∆pH/30 min method. The study was conducted by dividing the albino mice into four equal groups. G-I: control group, G-II: animals were treated with ciprofloxacin as one /day orally for 3 days, G-III: animals were treated with ciprofloxacin as one per/day orally for 7 days, and G-IV: animals were treated with ciprofloxacin one per/day orally for 14 days. The results showed that ciprofloxacin therapy raised the blood total cholesterol considerably and serum HDL, LDL, GOT, GPT, and Alkaline phosphatase significantly. There was a substantial decrease in triglyceride levels in the blood.
Keywords
Article Details
The authors transfer the copyrights of their papers to the Iranian Society of Ichthyology. However, the information could be used in accordance with the Creative Commons licence (Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
References
-
Adikwu, E. & Brambaifam, N. 2012. Ciprofloxacin cardio- toxicity and hepatoxicity in human and animals. Pharmacology 3: 207-213.
AL-Rikaby, A.A.; Ghadhban, R.F. & Majeed, S.K. 2016. The effects of ciprofloxacin on male rabbits: Biochemical and histopathological study. Al-Qadisiyah Journal of Veterinary Medicine Sciences 15(1): 38-44.
Aqeel, H. & Atallah, A. 2021. Study the Effect of Ciprofloxacin on Cholinesterase in Different Organs of Mice. Iraqi Journal of Science 56(2A): 21456
Belfield D.M. 1971. Goldberg, colorimetric determination of alkaline phosphatase activity. Enzyme 12(5): 561-568.
Bergan, T.; Thorsteinsson, S.B.; Solberg, R.; Bjornskau, L.; Kolstad, I.M. & Johnson S. 1987. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. American Journal of Medicine 82: 97-102.
Bertino Jr, J. & Fish, D. 2000. The safety profile of the fluoroquinolones. Clinical therapeutics 22(7): 798-817.
Chalasani, N.; Fontana, R.J.; Bonkovsky, H.L.; Watkins, P.B.; Davern, T. & Serrano, J. 2000. Drug induced liver injury network (DILIN) causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135(6): 1924-1934.
Dana, E.K.; Robb, M. & Sandra, H.L. 2001. New classification and update on the quinolone antibiotics. Amer. Fam. Physic.
Dufour, R.; Lott, J.; Nolte, F.; Greth, D.; Koff, R. & Seef, L. 2000. Dignosis and monitoring of hepatic injury performance characteristic of laboratory test. Clinical Chemistry 46: 2027-2068.
Food and Drug Administration. 2005. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Rockville, Maryland, USA: US: Food and Drug Administration.
Friedewald, W.T.; Levy, R.T. & Frederickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clinical Chemistry 18: 499-502.
Gordon, T.; Castelli, W.P.; Hjortland, M.C.; Kannel, W.B. & Dawber, T.R. 1977. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. The American Journal of Medicine 62(5): 707-714.
Hyeon, C.K.; Chung, M.N.; Sun, H.J.; Kwang, H.H.; Oh, D.K. & Suh, I. 2004. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 328(7446): 983.
Liu, Q. & Wong, J.C. 1999. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerase. Proceedings of the National Academy of Sciences 96: 881-886.
Qutrio Baloch, Z.; Raza, M.A. & Abbas, S.A. 2017. Ciprofloxacin-induced Hepatotoxicity in a Healthy Young Adult. Cureus 9: e1016.
Reitman, S. & Frankel, S. 1957. A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases. American Journal of Clinical Pathology 28: 56-63.
Rosenthal, P. 1997. Assessing liver function and Hyperbilirubinemia in the newborn. Clinical Chemistry 43(1): 228-234.
Schettler, G. & Nussel, E. 1975. Determination of serum total cholesterol by enzymatic Colorimetric test. Arbeitsmedizin, Sozialmedizin, Präventivmedizin Sonderheft 10: 25.
Widmaier, E.P.; Raff, H. & Strang, K.T. 2006. Vander’s Human Physiology, the Mechanisms of Body Function. 10th ed., McGraw-Hill, pp. 575-583.
Zimmerman, H.J. 2000. Drug-induced liver disease. Clinics in Liver Disease 4.1(2000): 73-96.
References
AL-Rikaby, A.A.; Ghadhban, R.F. & Majeed, S.K. 2016. The effects of ciprofloxacin on male rabbits: Biochemical and histopathological study. Al-Qadisiyah Journal of Veterinary Medicine Sciences 15(1): 38-44.
Aqeel, H. & Atallah, A. 2021. Study the Effect of Ciprofloxacin on Cholinesterase in Different Organs of Mice. Iraqi Journal of Science 56(2A): 21456
Belfield D.M. 1971. Goldberg, colorimetric determination of alkaline phosphatase activity. Enzyme 12(5): 561-568.
Bergan, T.; Thorsteinsson, S.B.; Solberg, R.; Bjornskau, L.; Kolstad, I.M. & Johnson S. 1987. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. American Journal of Medicine 82: 97-102.
Bertino Jr, J. & Fish, D. 2000. The safety profile of the fluoroquinolones. Clinical therapeutics 22(7): 798-817.
Chalasani, N.; Fontana, R.J.; Bonkovsky, H.L.; Watkins, P.B.; Davern, T. & Serrano, J. 2000. Drug induced liver injury network (DILIN) causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135(6): 1924-1934.
Dana, E.K.; Robb, M. & Sandra, H.L. 2001. New classification and update on the quinolone antibiotics. Amer. Fam. Physic.
Dufour, R.; Lott, J.; Nolte, F.; Greth, D.; Koff, R. & Seef, L. 2000. Dignosis and monitoring of hepatic injury performance characteristic of laboratory test. Clinical Chemistry 46: 2027-2068.
Food and Drug Administration. 2005. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Rockville, Maryland, USA: US: Food and Drug Administration.
Friedewald, W.T.; Levy, R.T. & Frederickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clinical Chemistry 18: 499-502.
Gordon, T.; Castelli, W.P.; Hjortland, M.C.; Kannel, W.B. & Dawber, T.R. 1977. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. The American Journal of Medicine 62(5): 707-714.
Hyeon, C.K.; Chung, M.N.; Sun, H.J.; Kwang, H.H.; Oh, D.K. & Suh, I. 2004. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 328(7446): 983.
Liu, Q. & Wong, J.C. 1999. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerase. Proceedings of the National Academy of Sciences 96: 881-886.
Qutrio Baloch, Z.; Raza, M.A. & Abbas, S.A. 2017. Ciprofloxacin-induced Hepatotoxicity in a Healthy Young Adult. Cureus 9: e1016.
Reitman, S. & Frankel, S. 1957. A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases. American Journal of Clinical Pathology 28: 56-63.
Rosenthal, P. 1997. Assessing liver function and Hyperbilirubinemia in the newborn. Clinical Chemistry 43(1): 228-234.
Schettler, G. & Nussel, E. 1975. Determination of serum total cholesterol by enzymatic Colorimetric test. Arbeitsmedizin, Sozialmedizin, Präventivmedizin Sonderheft 10: 25.
Widmaier, E.P.; Raff, H. & Strang, K.T. 2006. Vander’s Human Physiology, the Mechanisms of Body Function. 10th ed., McGraw-Hill, pp. 575-583.
Zimmerman, H.J. 2000. Drug-induced liver disease. Clinics in Liver Disease 4.1(2000): 73-96.